Substituted hydroxyapatites
Investigator: Muhammad Maqbool (Doktorand, am Lucideon Ltd.)
email: muhammad.maqbool@fau.de
Supervisor: Prof. Dr.-Ing. habil. Aldo R. Boccaccini
Industrial Supervisors: Dr. Xiang Zhang, Mr. Ben McCarthy (LUCIDEON UK)
This research project is being carried out in the framework of the Innovative Training Network-European Industrial Doctorate (ITN-EID) titled "Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications (HyMedPoly)". HyMedPoly has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 643050. This project will be carried out in close collaboration with the industrial partner Lucideon Limited UK. The aim of this project is to develop and characterize substituted hydroxyapatite bioceramics for antibacterial applications by optimisation of novel synthesis routes. The new materials will be fully characterized in terms of physicochemical properties, antibacterial functionality and biological compatibility in order to assess its suitability for biomedical applications.
